Author

Matthew Kin-Liang Chiu

Institute of Cancer ResearchORCID 0009-0007-7189-5883Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Alan A. MelcheriD· 1 shared Anton PatrikeeviD· 1 shared Edward John Lloyd Armstrong· 1 shared Emmanuel Christian PatiniD· 1 shared Fiona Errington‐MaisiD· 1 shared Galabina Bozhanova· 1 shared Joan KyulaiD· 1 shared John Cameron BelliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alan A. MelcherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyJournal for ImmunoTherapy of CancerPeer-reviewedJul 1, 2024

Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T cell receptor signalling.

Edward John Lloyd Armstrong, Matthew Kin-Liang Chiu, Shane Foo…·Victoria A. Jennings

This study shows that combining oncolytic Maraba virus with PD-1 blockade overcomes resistance in advanced melanoma with a cold tumor microenvironment.

16 citations

mousebulk RNA-seq

𝕏 PostBluesky